Literature DB >> 2909018

Susceptibility to influenza A in HIV-positive patients.

J P Cohen, C Macauley.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2909018     DOI： 10.1001/jama.1989.03420020097023

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.

Authors:  Hana M El Sahly; Charles Davis; Karen Kotloff; Jeffery Meier; Patricia L Winokur; Anna Wald; Christine Johnston; Sarah L George; Rebecca C Brady; Corinne Lehmann; Abbie Stokes-Riner; Wendy A Keitel
Journal:  J Infect Dis       Date:  2012-01-24       Impact factor: 5.226

Review 2.  Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Authors:  Anandi N Sheth; Keri N Althoff; John T Brooks
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

Review 3.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

4.  Increased influenza-specific antibody avidity in HIV-infected women compared with HIV-infected men on antiretroviral therapy.

Authors:  Zhenwu Luo; Elizabeth Ogunrinde; Min Li; Lumin Zhang; Lisa Martin; Zejun Zhou; Zhiliang Hu; Tao Zhang; Zhen Li; Jiafeng Zhang; Bin Su; Tong Zhang; Hao Wu; Lei Ma; Guoyang Liao; Allison Ross Eckard; Maria Anna Julia Westerink; Sonya L Heath; Wei Jiang
Journal:  AIDS       Date:  2019-01-27       Impact factor: 4.177

5.  Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells.

Authors:  Lorenzo A Ramirez; Alexander Daniel; Ian Frank; Pablo Tebas; Jean D Boyer
Journal:  J Infect Dis       Date:  2014-03-08       Impact factor: 5.226

6.  Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.

Authors:  Zhenwu Luo; Lei Ma; Lumin Zhang; Lisa Martin; Zhuang Wan; Stephanie Warth; Andrew Kilby; Yong Gao; Pallavi Bhargava; Zhen Li; Hao Wu; Eric G Meissner; Zihai Li; J Michael Kilby; Guoyang Liao; Wei Jiang
Journal:  Vaccine       Date:  2015-12-22       Impact factor: 3.641

7.  The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.

Authors:  Anna M Powell; Zhenwu Luo; Lisa Martin; Zhuang Wan; Lei Ma; Guoyang Liao; Yuxia Song; Xiaochun Li; J Michael Kilby; Lei Huang; Wei Jiang
Journal:  Vaccine       Date:  2016-12-22       Impact factor: 3.641

8.  Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals.

Authors:  C A Benne; F P Kroon; M Harmsen; L Tavares; C A Kraaijeveld; J C De Jong
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 9.  Humoral immune response to influenza vaccination in patients from high risk groups.

Authors:  L B Brydak; M Machala
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

10.  Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.

Authors:  Keri N Althoff; Maryna Eichelberger; Stephen J Gange; Gerald B Sharp; Jin Gao; Marshall J Glesby; Mary Young; Ruth M Greenblatt; Audrey L French; Maria C Villacres; Howard Minkoff
Journal:  AIDS       Date:  2011-06-01       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.